AGTR1 and hypertensive disorder: Therefore, in current guideline-directed medical therapy related to the RAS, pharmacological blockade of this axis either by ACE inhibitors (ACEi) or AT1 receptor antagonists is the golden standard for the treatment of hypertension, HF and CKD [9–11].